The US home diagnostics for urinary tract infection market is expected to reach US$ 444.91 million by 2027 from US$ 267.44 million in 2019; it is expected to grow at a CAGR of 6.7% from 2020 to 2027.
The growth of the market is attributed to the key factors such as the growing UTI prevalence and increasing geriatric population. However, inaccuracy in the results of home UTI screening tests is the major factor hindering its market.
Advancements in the global healthcare sector and increasing emphasis on self care as well as preventive care lead to the emergence of home-based diagnostics.The medical device manufacturers focus on the implementation of new designs and prototypes to offer significant care to patients at home.
Home diagnostics confer improved patient care and experience and superior patient convenience, and incur lower cost.Moreover, the introduction of advanced diagnostics products for UTI detection is also projected to increase the adoption of home diagnostics products in the coming years.
Further, the increasing emphasis of government authorities to encourage home care provides significant opportunities for the growth of the market players.As per the American Urological Association, November is Bladder Health Awareness Month that serves as a reminder to Americans to gain the knowledge about common bladder health conditions and proactively take initiatives to take care of bladder health.
National Health Observance, the Urology Care Foundation sponsored by the US Department of Health and Human Services, is the world’s leading nonprofit urological health foundation.
Based on form type, the US home diagnostics for urinary tract infection market is segmented into dipsticks, cups, dipslides, cassettes, and others.In 2019, the dipsticks segment held the largest share of the market and is anticipated to register the highest CAGR during the forecast period.
Based on distribution channel, the US home diagnostics for urinary tract infection market is segmented into retail pharmacies and drug stores, supermarkets/hypermarkets, and online pharmacies.The retail pharmacies and drug stores segment held the largest share of the market in 2019.
The market for online pharmacies is anticipated to grow at the fastest CAGR during the forecast period.
A few of the major primary and secondary sources referred to while preparing this report on the US home diagnostics for urinary tract infection market are Chronic Kidney Disease (CKD), National Statistics Institute (NSI), Food and Drug Administration (FDA), and Centers for Disease Control and Prevention (CDC).
Our reports have been used by over 10K customers, including:
Non Alcoholic Fatty Liver Disease (NAFLD) (Gastrointestinal) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Non Alcoholic Fatty Liver Disease - Drugs in Development, 2021, provides an overview of the Non Alcoholic Fatty Liver Disease (Gastrointestinal)...
Patient history: The industry will likely benefit from new-and-improved service capability advances Abstract Diagnostic & Medical Laboratories in the US Operators in the Diagnostic and Medical Laboratories industry are an integral part of patients’ medical evaluation and treatment. Laboratories are...
The Asia Pacific organoids market is expected to reach US$ 513.74 million in 2027 from US$ 97.02 million in 2019. The market is estimated to grow at a CAGR of 23.1% from 2020 to 2027. Rising adoption of biobanking and tumor modelling and alternatives for animal testing models acting as kingpins are expected to augment the growth of the...
The Europe organoids market is projected to reach US$ 1,260.08 million by 2027 from US$ 247.85 million in 2019; it is estimated to grow at a CAGR of 22.5% from 2020 to 2027. Increasing demand for tumor modelling and biobanking and rising adoption of personalized drugs are expected to drive the market. Personalized medicine is a growing...
The Middle East & Africa organoids market is expected to reach US$ 141.26 million in 2027 from US$ 37.34 million in 2019; the market is estimated to grow at a CAGR of 20.9% from 2020 to 2027. The growth of the market can be attributed to growing research on organoids in the Middle East & Africa region and rising focus on developing alternatives...
The North America organoids market is expected to reach US$ 1,406.47 million by 2027 from US$ 291.39 million in 2019. The market is anticipated to grow at a CAGR of 21.7% from 2020 to 2027. Growth of the North America organoids market is attributed to emergence of three-dimensional (3D) organoids and rise in investments in research. However,...
The South and Central America nurse call systems market is expected to reach US$ 200.11 million by 2027 from US$ 87.23 million in 2019. The market is estimated to grow at a CAGR of 10.8% from 2020-2027. The growth of the South and Central America nurse call systems market is driven by the growing incidence of Alzheimer’s disease and dementia...
The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period. The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R&D spending & healthcare expenditure. Emerging markets are expected...
The global organoids market is expected to reach US$ 3,420.40 million by 2027 from US$ 689.47 million in 2019. The market is estimated to grow at a CAGR of 22.1% from 2020 to 2027. Increasing demand for tumor modelling and biobanking, rising adoption of personalized drugs, and growing focus on developing alternatives for animal testing...
Melanoma - Global Drug Forecast and Market Analysis to 2029
Melanoma of the skin is a serious and aggressive form of cancer originating from melanocytes, the pigment cells in skin, and can develop anywhere on the body.Although melanoma has high survivability, it remains a significant health...
Health Care Provider
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.